BLB [BLBLIMITED] vs Shalimar Agencies [SAGL] Detailed Stock Comparison
BLB
NSE
Loading...
Shalimar Agencies
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: BLB wins in 10 metrics, Shalimar Agencies wins in 7 metrics, with 0 ties. BLB appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | BLB | Shalimar Agencies | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.02 | 484.00 | BLB |
| Price-to-Book Ratio | 0.89 | 25.93 | BLB |
| Debt-to-Equity Ratio | 0.53 | 64.93 | BLB |
| PEG Ratio | -0.13 | N/A | N/A |
| EV/EBITDA | 11.29 | 209.75 | BLB |
| Profit Margin (TTM) | 1.85% | 5.31% | Shalimar Agencies |
| Operating Margin (TTM) | 26.27% | -0.17% | BLB |
| EBITDA Margin (TTM) | 26.27% | N/A | N/A |
| Return on Equity | 3.97% | 10.13% | Shalimar Agencies |
| Return on Assets (TTM) | 3.93% | 6.39% | Shalimar Agencies |
| Free Cash Flow (TTM) | $-15.86M | $28.16M | Shalimar Agencies |
| 1-Year Return | -10.82% | 775.00% | Shalimar Agencies |
| Price-to-Sales Ratio (TTM) | 0.24 | 25.37 | BLB |
| Enterprise Value | $647.06M | $29.99B | Shalimar Agencies |
| EV/Revenue Ratio | 0.18 | 28.19 | BLB |
| Gross Profit Margin (TTM) | 27.72% | 39.53% | Shalimar Agencies |
| Revenue per Share (TTM) | $68 | $2 | BLB |
| Earnings per Share (Diluted) | $1.26 | $0.08 | BLB |
| Beta (Stock Volatility) | -0.30 | 0.38 | BLB |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
BLB vs Shalimar Agencies Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| BLB | -0.30% | -4.60% | 12.33% | 8.75% | -8.48% | -15.85% |
| Shalimar Agencies | 1.98% | 1.87% | 19.01% | 141.89% | 194.66% | 321.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| BLB | -10.82% | -18.00% | 241.67% | 277.01% | 54.72% | 30.16% |
| Shalimar Agencies | 775.00% | 1,056.61% | 3,369.83% | 2,619.59% | 2,619.59% | 2,619.59% |
Performance & Financial Health Analysis: BLB vs Shalimar Agencies
| Metric | BLBLIMITED | SAGL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹867.52M | ₹26.99B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 400,044 | 25,006 |
| 90 Day Avg. Volume | 200,365 | 25,151 |
| Last Close | ₹16.35 | ₹40.25 |
| 52 Week Range | ₹13.10 - ₹24.95 | ₹4.60 - ₹41.13 |
| % from 52W High | -34.47% | -2.14% |
| All-Time High | ₹84.55 (Dec 31, 2007) | ₹41.13 (Aug 05, 2025) |
| % from All-Time High | -80.66% | -2.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.76% | -0.34% |
| Quarterly Earnings Growth | 0.32% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.05% |
| Operating Margin (TTM) | 0.26% | 0.00% |
| Return on Equity (TTM) | 0.04% | 0.10% |
| Debt to Equity (MRQ) | 0.53 | 64.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹18.42 | ₹1.49 |
| Cash per Share (MRQ) | ₹4.26 | ₹0.03 |
| Operating Cash Flow (TTM) | ₹15.77M | ₹29.07M |
| Levered Free Cash Flow (TTM) | ₹38.61M | ₹-259,215,120 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: BLB vs Shalimar Agencies
| Metric | BLBLIMITED | SAGL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.02 | 484.00 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.13 | N/A |
| Price to Sales (TTM) | 0.24 | 25.37 |
| Price to Book (MRQ) | 0.89 | 25.93 |
| Market Capitalization | ||
| Market Capitalization | ₹867.52M | ₹26.99B |
| Enterprise Value | ₹647.06M | ₹29.99B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.18 | 28.19 |
| Enterprise to EBITDA | 11.29 | 209.75 |
| Risk & Other Metrics | ||
| Beta | -0.30 | 0.38 |
| Book Value per Share (MRQ) | ₹18.42 | ₹1.49 |
Financial Statements Comparison: BLB vs Shalimar Agencies
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BLBLIMITED | SAGL |
|---|---|---|
| Revenue/Sales | ₹564.20M | ₹347.63M |
| Cost of Goods Sold | ₹407.80M | ₹210.20M |
| Gross Profit | ₹156.40M | ₹137.43M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹147.70M | ₹-4.84M |
| EBITDA | ₹151.90M | ₹9.66M |
| Pre-Tax Income | ₹148.40M | ₹-20.23M |
| Income Tax | ₹33.50M | ₹16.18M |
| Net Income (Profit) | ₹114.90M | ₹-36.41M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BLBLIMITED | SAGL |
|---|---|---|
| Cash & Equivalents | ₹37.84M | ₹24.44M |
| Total Current Assets | ₹682.14M | ₹616.36M |
| Total Current Liabilities | ₹9.34M | ₹296.84M |
| Long-Term Debt | N/A | ₹647.34M |
| Total Shareholders Equity | ₹973.59M | ₹1.09B |
| Retained Earnings | ₹602.46M | N/A |
| Property, Plant & Equipment | ₹3.22M | ₹210.45M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BLBLIMITED | SAGL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BLBLIMITED | SAGL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 400,044 | 25,006 |
| Average Daily Volume (90 Day) | 200,365 | 25,151 |
| Shares Outstanding | 52.87M | 697.12M |
| Float Shares | 20.11M | N/A |
| % Held by Insiders | 0.72% | 0.83% |
| % Held by Institutions | 0.00% | 0.17% |
Dividend Analysis & Yield Comparison: BLB vs Shalimar Agencies
| Metric | BLBLIMITED | SAGL |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |